Alpha Cognition Inc (ACOG)
Grapevine, BC, US
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Based on only 1 article — low confidence
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.38% | -3.57% | -0.34% | +21.92% | -2.94% | -8.46% | -13.89% | -16.20% | -16.20% | -16.20% | -16.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
14.00
+72.6%
|
| Last Quarter | 1 |
14.00
+72.6%
|
| Last Year | 2 |
16.00
+97.3%
|
| All Time | 2 |
16.00
+97.3%
|
-
Revenue growth Financial - Conglomerates: +32.7%— Q1'26: +20.7% (vs Q1'25)
-
EPS growth Financial - Conglomerates: +16.6%+42.1% ★ Q1'26: -146.2% (vs Q1'25)
-
FCF margin FCF growth · Financial - Conglomerates: +2.3%-267.5% Q1'26: -333.9% (vs Q1'25)
-
EBIT margin Financial - Conglomerates: +36.2%-221.7% Q1'26: +0.0% (vs Q1'25)
-
ROIC Financial - Conglomerates: +2.2%—
-
Share dilution Financial - Conglomerates: +0.0%+143.9% Q1'26: +36.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Financial - Conglomerates: 2.57×0.00× Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
—
|
10.22M
est: 10.61M (-3.7%)
|
23.38M
22.43M – 24.33M
+120.3% YoY
|
51.87M
49.65M – 54.08M
+121.9% YoY
|
89.60M
81.94M – 97.25M
+72.7% YoY
|
| EBITDA |
-14.37M
|
-22.66M
est: 6.37M (-455.9%)
|
14.03M
13.46M – 14.60M
+120.3% YoY
|
31.12M
29.79M – 32.45M
+121.9% YoY
|
53.76M
49.16M – 58.35M
+72.7% YoY
|
| EBIT |
-14.45M
|
-22.66M
est: 6.37M (-455.9%)
|
14.03M
13.46M – 14.60M
+120.3% YoY
|
31.12M
29.79M – 32.45M
+121.9% YoY
|
53.76M
49.16M – 58.35M
+72.7% YoY
|
| Net Income |
-14.64M
est: -11.63M (-25.8%)
|
-20.67M
est: -19.71M (-4.8%)
|
-24.16M
-28.67M – -19.66M
-22.6% YoY
|
-7.96M
-10.31M – -5.60M
+67.1% YoY
|
14.14M
12.57M – 15.72M
+277.8% YoY
|
| SGA |
7.32M
|
29.08M
est: 14.53M (+100.2%)
|
32.01M
30.71M – 33.30M
+120.3% YoY
|
71.01M
67.98M – 74.03M
+121.9% YoY
|
122.66M
112.18M – 133.14M
+72.7% YoY
|
| EPS |
-2.02
est: -1.61 (-25.9%)
|
-1.17
est: -1.12 (-4.9%)
|
-1.37
-1.62 – -1.11
-22.6% YoY
|
-0.45
-0.58 – -0.32
+67.1% YoY
|
0.80
0.71 – 0.89
+277.8% YoY
|
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-27 | HC Wainwright & Co. | Buy | Buy | Maintain |
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | John Havens | 319.2K | 5.30% | 319.2K | — | 319.2K | — | IN | — | 2024-11-15 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | OPALEYE MANAGEMENT INC. | 2.07M +2.0M (+1,698.5%) | 13.46M +12.7M (+1,695.7%) | 12.83% +12.108 pp | 1.78% +1.670 pp | USD6.50 +0.0% | 2 qtrs — |
| 2 | SOLAS CAPITAL MANAGEMENT, LLC | 1.97M +685.9K (+53.5%) | 12.79M +4.4M (+53.3%) | 12.19% +4.187 pp | 7.26% +2.164 pp | USD6.10 +6.6% | 5 qtrs — |
| 3 | AWM INVESTMENT COMPANY, INC. | 1.67M +576.5K (+52.6%) | 10.87M +3.7M (+52.4%) | 10.36% +3.519 pp | 1.05% +0.381 pp | USD5.56 +16.9% | 4 qtrs — |
| 4 | CABLE CAR CAPITAL LLC | 1.06M +191.2K (+22.0%) | 6.89M +1.2M (+21.8%) | 6.57% +1.143 pp | 0.23% -2.195 pp | USD7.15 -9.1% | 5 qtrs — |
| 5 | IKARIAN CAPITAL, LLC | 1.06M +110.0K (+11.6%) | 6.87M +705.5K (+11.5%) | 6.54% +0.636 pp | 0.54% -0.086 pp | USD5.81 +11.9% | 5 qtrs — |
| 6 | SPHERA FUNDS MANAGEMENT LTD. | 567.6K +228.9K (+67.6%) | 3.69M +1.5M (+67.3%) | 3.52% +1.402 pp | 0.71% +0.248 pp | USD6.14 +5.9% | 5 qtrs — |
| 7 | ALYESKA INVESTMENT GROUP, L.P. | 365.0K +365.0K (+100.0%) | 2.37M +2.4M (+100.0%) | 2.26% +2.261 pp | 0.01% +0.007 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 8 | BOOTHBAY FUND MANAGEMENT, LLC | 256.4K -35.5K (-12.2%) | 1.67M -233.5K (-12.3%) | 1.59% -0.234 pp | 0.02% -0.003 pp | USD5.78 +12.5% | 5 qtrs — |
| 9 | ARISTIDES CAPITAL LLC | 215.5K +50.0K (+30.2%) | 1.40M +323.3K (+30.0%) | 1.33% +0.302 pp | 0.25% +0.092 pp | USD6.03 +7.8% | 5 qtrs — |
| 10 | CANTOR FITZGERALD, L. P. | 163.4K +163.4K (+100.0%) | 1.06M +1.1M (+100.0%) | 1.01% +1.012 pp | 0.02% +0.016 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 11 | CITADEL ADVISORS LLC | 118.4K +118.4K (+100.0%) | 769.7K +769.7K (+100.0%) | 0.73% +0.734 pp | 0.00% +0.000 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 12 | VILLERE ST DENIS J & CO LLC | 73.9K +8.6K (+13.2%) | 480.2K +55.4K (+13.0%) | 0.46% +0.050 pp | 0.05% +0.007 pp | USD5.49 +18.4% | 5 qtrs — |
| 13 | TUDOR INVESTMENT CORP ET AL | 61.6K +— (+0.0%) | 400.4K -616.0 (-0.2%) | 0.38% -0.003 pp | 0.00% +0.000 pp | USD5.89 +10.4% | 5 qtrs — |
| 14 | TWO SIGMA INVESTMENTS, LP | 57.6K +34.8K (+153.3%) | 374.2K +226.3K (+152.9%) | 0.36% +0.215 pp | 0.00% +0.000 pp | USD6.50 +0.0% | 2 qtrs — |
| 15 | MARSHALL WACE, LLP | 53.2K -19.0K (-26.3%) | 345.8K -124.3K (-26.4%) | 0.33% -0.121 pp | 0.00% 0.000 pp | USD9.02 -27.9% | 3 qtrs — |
| 16 | ACT CAPITAL MANAGEMENT, LLC | 51.5K +51.5K (+100.0%) | 334.8K +334.8K (+100.0%) | 0.32% +0.319 pp | 0.27% +0.271 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34.7K +34.7K (+100.0%) | 225.6K +225.6K (+100.0%) | 0.22% +0.215 pp | 0.00% +0.000 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 18 | BERKSHIRE ASSET MANAGEMENT LLC/PA | 19.8K +2.0K (+11.2%) | 128.9K +12.8K (+11.1%) | 0.12% +0.012 pp | 0.01% +0.001 pp | USD8.19 -20.6% | 3 qtrs — |
| 19 | QUADRATURE CAPITAL LTD | 12.5K -1.1K (-8.4%) | 81.3K -7.6K (-8.5%) | 0.08% -0.008 pp | 0.00% 0.000 pp | USD6.51 -0.2% | 2 qtrs — |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 12.0K +— (+0.0%) | 77.9K -119.0 (-0.2%) | 0.07% -0.001 pp | 0.00% +0.000 pp | USD9.33 -30.3% | 3 qtrs — |
| 21 | GREEN ALPHA ADVISORS, LLC | 11.1K +11.1K (+100.0%) | 72.3K +72.3K (+100.0%) | 0.07% +0.069 pp | 0.07% +0.066 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 22 | NATIONAL BANK OF CANADA /FI/ | 5.3K +— (+0.0%) | 34.4K +267.0 (+0.8%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD5.96 +9.1% | 5 qtrs — |
| 23 | UBS GROUP AG | 927.00 +786.0 (+557.4%) | 6.0K +5.1K (+556.4%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD6.93 -6.2% | 5 qtrs — |
| 24 | ALLWORTH FINANCIAL LP | 750.00 +750.0 (+100.0%) | 4.9K +4.9K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD6.50 +0.0% | 1 qtrs NEW |
| 25 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 200.00 +— (+0.0%) | 1.3K -2.0 (-0.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +10.4% | 5 qtrs — |
| 26 | ROYAL BANK OF CANADA | 122.00 +— (+0.0%) | 1.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.89 +10.4% | 5 qtrs — |
| 27 | PNC FINANCIAL SERVICES GROUP, INC. | 120.00 +— (+0.0%) | 780.00 -1.0 (-0.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.88 +10.5% | 5 qtrs — |
| 28 | ZULLO INVESTMENT GROUP, INC. | — -19.5K (-100.0%) | — -126.9K (-100.0%) | 0.00% -0.122 pp | 0.00% -0.047 pp | USD— | 2 qtrs SOLD |
| 29 | CONNECTIVE CAPITAL MANAGEMENT, LLC | — -47.9K (-100.0%) | — -312.0K (-100.0%) | 0.00% -0.299 pp | 0.00% -0.286 pp | USD— | 2 qtrs SOLD |
| 30 | CORSAIR CAPITAL MANAGEMENT, L.P. | — -134.9K (-100.0%) | — -878.2K (-100.0%) | 0.00% -0.842 pp | 0.00% -0.145 pp | USD— | 5 qtrs SOLD |
| 31 | JONES FINANCIAL COMPANIES LLLP | — -200.0 (-100.0%) | — -1.4K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 32 | MILLENNIUM MANAGEMENT LLC | — -17.3K (-100.0%) | — -112.3K (-100.0%) | 0.00% -0.108 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 33 | MORGAN STANLEY | — -840.0 (-100.0%) | — -5.5K (-100.0%) | 0.00% -0.005 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 34 | SALEM INVESTMENT COUNSELORS INC | — -45.4K (-100.0%) | — -295.6K (-100.0%) | 0.00% -0.283 pp | 0.00% -0.009 pp | USD— | 4 qtrs SOLD |
| 35 | TOWER RESEARCH CAPITAL LLC (TRC) | — -1.6K (-100.0%) | — -10.7K (-100.0%) | 0.00% -0.010 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Sensenig Bethany | Director | A-Award | A | Common Share Options | 6,991 | 6.65 | 46.5K | 6,991 | D | ↗ |
| 2026-04-15 | Sensenig Bethany | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-30 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,850 | 4.99 | 9.2K | 2,471,850 | I | ↗ |
| 2026-03-27 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 10,000 | 5.08 | 50.8K | 2,470,000 | I | ↗ |
| 2026-03-26 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 7,319 | 5.28 | 38.7K | 2,460,000 | I | ↗ |
| 2026-03-25 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 8,581 | 5.43 | 46.6K | 2,452,681 | I | ↗ |
| 2026-03-24 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 4,182 | 5.59 | 23.4K | 2,444,100 | I | ↗ |
| 2026-03-19 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,094 | 5.71 | 12.0K | 2,439,918 | I | ↗ |
| 2026-03-18 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,481 | 5.75 | 14.3K | 2,437,824 | I | ↗ |
| 2026-03-16 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,331 | 5.78 | 7.7K | 2,435,343 | I | ↗ |
| 2026-03-13 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 7,358 | 5.75 | 42.3K | 2,434,012 | I | ↗ |
| 2026-03-12 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 5,708 | 5.85 | 33.4K | 2,426,654 | I | ↗ |
| 2026-03-09 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,179 | 5.85 | 12.7K | 2,420,946 | I | ↗ |
| 2026-03-06 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 1,900 | 5.80 | 11.0K | 2,418,767 | I | ↗ |
| 2026-03-05 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 42,023 | 5.80 | 243.6K | 2,416,867 | I | ↗ |
| 2026-03-04 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 19,795 | 5.81 | 115.0K | 2,374,844 | I | ↗ |
| 2026-03-03 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 46,411 | 5.75 | 266.9K | 2,355,049 | I | ↗ |
| 2026-03-02 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 20,000 | 5.80 | 116.0K | 2,308,638 | I | ↗ |
| 2026-02-27 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 3,638 | 5.99 | 21.8K | 2,288,638 | I | ↗ |
| 2026-02-26 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 590 | 5.99 | 3.5K | 2,285,000 | I | ↗ |
| 2026-02-24 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 5,000 | 5.80 | 29.0K | 80,000 | I | ↗ |
| 2026-02-23 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 95,819 | 5.89 | 564.6K | 2,230,819 | I | ↗ |
| 2026-02-20 | Opaleye Management Inc. | 10% Owner | P-Purchase | A | Common Stock, no par value | 2,819 | 5.84 | 16.5K | 70,819 | I | ↗ |
| 2026-02-19 | Opaleye Management Inc. | 10% Owner | — | — | Common Stock, no par value | 0 | 0.00 | — | 2,125,000 | I | ↗ |
| 2026-01-14 | Wills Robert James | Director | A-Award | A | Common Share Options | 8,437 | 6.56 | 55.3K | 8,437 | D | ↗ |
| 2026-01-14 | MERTZ PHILLIP JOSEPH | Director | A-Award | A | Common Share Options | 8,437 | 6.56 | 55.3K | 8,437 | D | ↗ |
| 2026-01-14 | MERTZ LEONARD POWELL | Director | A-Award | A | Common Shares | 7,241 | 0.00 | — | 145,736 | D | ↗ |
| 2026-01-14 | CAWKELL KENNETH ANTHONY | Director | A-Award | A | Common Shares | 7,241 | 0.00 | — | 107,740 | D | ↗ |
| 2026-01-14 | BAKSHI RAJEEV KUMAR | Director | A-Award | A | Common Share Options | 8,437 | 6.56 | 55.3K | 8,437 | D | ↗ |
| 2026-01-09 | McFadden Michael E. | Director / Officer | A-Award | A | Performance Share Units | 76,220 | 6.56 | 500.0K | 76,220 | D | ↗ |
| 2026-01-09 | DU HENRY HUY | Officer | A-Award | A | Common Share Options | 15,982 | 6.56 | 104.8K | 15,982 | D | ↗ |
| 2026-01-09 | D'Angelo Lauren | Officer | A-Award | A | Common Share Options | 106,545 | 6.56 | 698.9K | 106,545 | D | ↗ |
| 2025-08-18 | Wills Robert James | Director | P-Purchase | A | Common Stock | 15,000 | 8.49 | 127.3K | 15,000 | D | ↗ |
| 2025-08-18 | MERTZ PHILLIP JOSEPH | Director | S-Sale | D | Common Shares | 27,778 | 9.00 | 250.0K | 22,462 | D | ↗ |
| 2025-08-18 | MERTZ LEONARD POWELL | Director | P-Purchase | A | Common Shares | 27,778 | 9.00 | 250.0K | 121,503 | I | ↗ |
| 2025-04-07 | Wills Robert James | Director | A-Award | A | Director Stock Option (Right to Buy) | 30,019 | 4.43 | 133.0K | 30,019 | D | ↗ |
| 2025-02-25 | HAVENS JOHN PRENTISS | Director | A-Award | A | Common Share Options | 38,762 | 5.93 | 229.9K | 38,762 | D | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Michael McFadden Chief Executive Officer | 625.0K | 468.8K | — | 2.50M | — | 30.4K | 3.62M | 68.98% | ↗ |
| 2 | 2025 | Lauren D’Angelo Chief Commercial Officer and Chief Operating Officer | 500.0K | 375.0K | — | 1.50M | — | 33.6K | 2.41M | 62.28% | ↗ |
| 3 | 2025 | Henry Du Interim Chief Financial Officer | 285.0K | 147.9K | — | — | — | 31.6K | 464.5K | 0.00% | ↗ |
| 4 | 2024 | Michael McFadden Chief Executive Officer | 500.0K | 412.5K | — | — | — | 31.2K | 943.7K | 0.00% | ↗ |
| 5 | 2024 | Lauren D’Angelo Chief Commercial Officer and Chief Operating Officer | 420.0K | 346.5K | — | — | — | 31.2K | 797.7K | 0.00% | ↗ |
| 6 | 2024 | Michael McFadden Chief Executive Officer | 500.0K | 255.0K | — | — | — | 31.2K | 786.2K | 0.00% | ↗ |
| 7 | 2024 | Lauren D’Angelo Chief Commercial Officer and Chief Operating Officer | 420.0K | 209.2K | — | — | — | 31.2K | 660.3K | 0.00% | ↗ |
| 8 | 2024 | Don Kalkofen Former Chief Financial Officer | 355.3K | 214.2K | — | — | — | 19.6K | 589.1K | 0.00% | ↗ |
| 9 | 2024 | Henry Du Interim Chief Financial Officer | 54.4K | 38.5K | — | 267.3K | — | 3.3K | 363.6K | 73.53% | ↗ |
| 10 | 2023 | Michael McFadden Chief Executive Officer | 500.0K | 125.0K | — | 1.51M | — | 30.2K | 2.16M | 69.70% | ↗ |
| 11 | 2023 | Don Kalkofen Former Chief Financial Officer | 420.0K | 76.4K | — | 727.6K | — | 49.7K | 1.27M | 57.13% | ↗ |
| 12 | 2023 | Lauren D’Angelo Chief Commercial Officer and Chief Operating Officer | 410.1K | 89.9K | — | 684.2K | — | 30.2K | 1.21M | 56.34% | ↗ |
| 13 | 2022 | Michael McFadden Chief Executive Officer | 500.0K | 483.2K | — | 57.5K | — | 28.6K | 1.07M | 5.38% | ↗ |
| 14 | 2022 | Lauren D’Angelo Chief Commercial Officer and Chief Operating Officer | 359.7K | 195.4K | — | 132.7K | — | 25.6K | 712.3K | 18.63% | ↗ |
| 15 | 2022 | Don Kalkofen Former Chief Financial Officer | 305.5K | — | — | 381.8K | — | 16.4K | 703.6K | 54.27% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael E. McFadden | Chief Executive Officer & Director | 1M | male |
| Lauren D'Angelo | Chief Operating Officer | 908.6K | female |
| Denis G. Kay | Chief Scientific Officer | 180.0K | — |
| Kenneth Anthony Cawkell | Founder, Consultant, Corporate Secretary & Director | 51.0K | male |
| Amy Kincaid | Executive Director, Head of Marketing & Commercial Strategy | — | female |
| Timothy Ayers | Head of Compliance | — | male |
| Christine Reveal | Vice President of Marketing & Commercial Strategy | — | female |
| Henry Du | Vice President of Finance & Accounting and Interim Chief Financial Officer | — | male |
| Jack Kelly | Executive Director & Head of Market Access | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ACOG
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
